https://www.selleckchem.com/pr....oducts/leptomycinb.h
Some people with multiple sclerosis (pwMS) are at increased risk of severe Coronavirus disease 19 (COVID-19) and should be rapidly vaccinated. However, vaccine supplies are limited, and there are concerns about side-effects, particularly with the ChAdOx1nCoV-19 (AstraZeneca) vaccine. To report our first experience of pwMS receiving the AstraZeneca vaccine. Service evaluation. pwMS using the MS service at Barts Health NHS Trust were sent questionnaires to report symptoms following vaccination. Thirty-three responses were returned, 29
Like
Comment
Share
